CD4 and neoplasm: Key subsets of TILs include CD8+ cytotoxic T lymphocytes (CTLs), CD4+ helper T cells, regulatory T cells (Tregs), B cells, and natural killer (NK) cells—each playing distinct roles in shaping tumor immunity.